Abstract
An efficient synthesis of 2-substituted benzoxazoles via copper acetate monohydrate oxidative coupling of aldehydes with o-aminophenol is described. This synthetic strategy has some advantages as simple procedure, inexpensive and easily available catalyst, and facile isolation of the products in moderate to good yields.
Keywords: Benzoxazoles, aromatic aldehydes, o-aminophenol, copper acetate monohydrate, oxidative cyclization.
Letters in Organic Chemistry
Title:One-pot Synthesis of 2-Substituted Benzoxazoles Promoted by Copper Acetate Monohydrate
Volume: 11 Issue: 3
Author(s): Guo-Feng Chen, Hai-Dong Shen, Li-Yan Zhang, Hong-Yang Li, Rui-Jia Lan, Bao-Hua Chen, Ji-Tai Li and Qing-Hui Hu
Affiliation:
Keywords: Benzoxazoles, aromatic aldehydes, o-aminophenol, copper acetate monohydrate, oxidative cyclization.
Abstract: An efficient synthesis of 2-substituted benzoxazoles via copper acetate monohydrate oxidative coupling of aldehydes with o-aminophenol is described. This synthetic strategy has some advantages as simple procedure, inexpensive and easily available catalyst, and facile isolation of the products in moderate to good yields.
Export Options
About this article
Cite this article as:
Chen Guo-Feng, Shen Hai-Dong, Zhang Li-Yan, Li Hong-Yang, Lan Rui-Jia, Chen Bao-Hua, Li Ji-Tai and Hu Qing-Hui, One-pot Synthesis of 2-Substituted Benzoxazoles Promoted by Copper Acetate Monohydrate, Letters in Organic Chemistry 2014; 11 (3) . https://dx.doi.org/10.2174/15701786113106660070
DOI https://dx.doi.org/10.2174/15701786113106660070 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Metabolomics Applications in Precision Medicine: An Oncological Perspective
Current Topics in Medicinal Chemistry New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future Prospects
Reviews on Recent Clinical Trials Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
Current Alzheimer Research Oxidative Stress in the Pathogenesis/Treatment of Diabetes and its Complications
Current Nutrition & Food Science What Animal Models Have Taught us About Adenosine Receptor Function
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Advanced Structure-activity Relationships Applied to Mentha spicata L. Subsp. spicata Essential Oil Compounds as AChE and NMDA Ligands, in Comparison with Donepezil, Galantamine and Memantine – New Approach in Brain Disorders Pharmacology
CNS & Neurological Disorders - Drug Targets CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor-α Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
Current Neurovascular Research Neuropathological Correlates of Cerebral Multimorbidity
Current Alzheimer Research Foreword [Cannabinoid Special Issue (Guest Editor: Ruth A. Ross)]
Current Neuropharmacology The Impact of Omega-3 Fatty Acids on Osteoporosis
Current Pharmaceutical Design Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets Risk Factors of Alzheimers Disease Among Iranian Population
Current Alzheimer Research Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
Current Pharmaceutical Design DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Pharmacological Inhibition of PKR in APPswePS1dE9 Mice Transiently Prevents Inflammation at 12 Months of Age but Increases Aβ42 Levels in the Late Stages of the Alzheimer’s Disease
Current Alzheimer Research Adverse Drug Reaction Reporting Related to the Administration of Antibiotics in Hospitalized Pediatric Patients in Greece
Current Drug Safety Biphenyl-Derivatives Possessing Tertiary Amino Groups as β-Secretase (BACE1) Inhibitors
Letters in Drug Design & Discovery Complement System in SLE as a Target for Antibodies
Current Rheumatology Reviews Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part II
CNS & Neurological Disorders - Drug Targets